IVZ vs MXCT · rev $3.57B vs rev $16.9M
Invesco Plc (IVZ) versus MaxCyte Inc (MXCT) — a side-by-side from cached financials, not a winner call.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
Latest reported MXCT revenue for 2026-06-30 was $16.9M. Net income was -$13.6M. Revenue was up 75.3% from 2026-03-31 to 2026-06-30. MXCT currently screens at market cap $124.3M.
IVZ currently screens at market cap $12.76B. MXCT currently screens at market cap $124.3M.
Not investment advice. Open the IVZ and MXCT stock pages for the full models.
Not investment advice.